1. "Neuroblastoma Service"
Formats
  1. Journal Article (509)
  2. Meeting Abstract (295)
  3. Review (17)
  4. Book Section (14)
  5. Conference Paper (14)
  6. Editorial (5)
  7. Correspondence (2)
  8. Book Whole (1)
  9. Guidelines (1)
Groups
  1. Neuroblastoma Service (858)
  2. Pediatrics, Department of (858)
  3. GSK Faculty (682)
  4. Tow Center for Developmental Oncology (TCDO) (677)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (650)
  6. Center for Molecular Imaging and Biotechnology (427)

More Groups

People
  1. Nai-Kong Cheung (648)
  2. Brian Kushner (311)
  3. Shakeel Modak (249)
  4. Kim Kramer (176)
  5. Steven Larson (109)
  6. Stephen Roberts (107)

More People

Years
  1. 2025 (10)
  2. 2024 (26)
  3. 2023 (36)
  4. 2022 (44)
  5. 2021 (41)
  6. 2020 (49)

More Years

Publications
  1. Pediatric Blood and Cancer (115)
  2. Journal of Clinical Oncology (98)
  3. Cancer Research (41)
  4. Journal of Nuclear Medicine (36)
  5. Neuro-Oncology (32)
  6. Clinical Cancer Research (27)

More Publications

Publishers
  1. Wiley Periodicals, Inc (119)
  2. American Association for Cancer Research (102)
  3. American Society of Clinical Oncology (101)
  4. Elsevier Inc. (55)
  5. Oxford University Press (42)
  6. Society of Nuclear Medicine (36)

More Publishers

Results (858)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clinical impact of ALK mutations in neuroblastoma
    Meeting Abstract

    O'Donohue, T.; Gulati, N.; Shukla, N.; Roberts, S.; Basu, E.; Kushner, B.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Prognostic significance of ATRX aberrations in neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Kushner, B.; Cheung, N. K.; Shukla, N.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Phase 1/2 trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors
    Meeting Abstract

    Desai, A. V.; Gajjar, A.; Gauvain, K.; Basu, E. M.; Macy, M. E.; Maese, L.; Sabnis, A. J.; Foster, J.; Shusterman, S.; Yoon, J.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study
    Meeting Abstract

    Modak, S.; Kushner, B.; Flores, M.; Santa-Maria, V.; Garraus, M.; Basu, E.; Roberts, S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Phase I study of OKT3 x hu3F8 bispecific antibody (GD2Bi) armed T cells (GD2BATs) in GD2-positive tumors
    Meeting Abstract

    Yankelevich, M.; Modak, S.; Chu, R.; Lee, D. W.; Thakur, A.; Cheung, N. K. V.; Lum, L. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of convection-enhanced delivery of (124)I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma: An update with dose-response assessment
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Zhou, Z.; Zanzonico, P.; Donzelli, M.; Lyashchenko, S. K.; Haque, S.; Thakur, S. B.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors
    Meeting Abstract

    Robinson, G. W.; Gajjar, A. J.; Gauvain, K. M.; Basu, E. M.; Macy, M. E.; Maese, L. D.; Sabnis, A. J.; Foster, J. H.; Shusterman, S.; Yoon, J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of HITS pilot/phase II study
    Meeting Abstract

    Mora, J.; Kushner, B. H.; Flores, M. A.; Santa-Maria, V.; Garraus, M.; Basu, E. M.; Roberts, S. S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save